Fundies.
English

CORONADO BIOSCIENCES INC

EDGAR
CNDO Quarterly report (10-Q) · filed 2026-08-13

Annual consolidated revenue for 2025: about Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 63.26M, using the latest reported figures. The previous period, 2024, was about Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 57.68M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

18.7 million Unit_Standard_USD_gSwKTOVlr0ifEw1rEMmw0g

2026 Q2 · Unit_Standard_USD_gSwKTOVlr0ifEw1rEMmw0g

Exact inputs and evidence
  • Revenue: 18718000 Unit_Standard_USD_gSwKTOVlr0ifEw1rEMmw0g Source

Operating margin

-53.46%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -10006000 Unit_Standard_USD_gSwKTOVlr0ifEw1rEMmw0g Source
  • Revenue: 18718000 Unit_Standard_USD_gSwKTOVlr0ifEw1rEMmw0g Source
Cash and cash equivalents
197 million Unit_Standard_USD_gSwKTOVlr0ifEw1rEMmw0g Source
Exact value

196576000 Unit_Standard_USD_gSwKTOVlr0ifEw1rEMmw0g

Long-term debt including current maturities
35 million Unit_Standard_USD_gSwKTOVlr0ifEw1rEMmw0g Source
Exact value

35000000 Unit_Standard_USD_gSwKTOVlr0ifEw1rEMmw0g

Shares outstanding
33.3 million Unit_Standard_shares_C1E7FHVEnkyzt-8_jEEv0Q Source
Exact value

33311012 Unit_Standard_shares_C1E7FHVEnkyzt-8_jEEv0Q

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2025-12-31
  • Operating income: 2 of 11 periods available· newest 2025-12-31
  • Net income: 2 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2024-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • Long-term debt including current maturities: Multiple units; comparison withheld· newest 2025-12-31
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +9.7%

    Prior period

    Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 57.68 million

    –

    Current period

    Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 63.26 million

    –

    Exact inputs and evidence

    63262000 − 57675000 = 5587000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw

    57675000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    63262000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 52.81 million

    Prior period

    −Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 46 million

    –

    Current period

    Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 6.82 million

    –

    Exact inputs and evidence

    6815000 − -45997000 = 52812000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw

    -45997000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    6815000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 14.41 million

    Prior period

    −Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 80.19 million

    –

    Current period

    −Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 65.78 million

    –

    Exact inputs and evidence

    -65777000 − -80191000 = 14414000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw

    -80191000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -65777000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 63.26 million 100% of revenue
  • Operating costs Derived Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 133.48 million 211% of revenue
  • Operating income −Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 70.22 million −111% of revenue
  • Tax, interest and other Derived −Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 77.04 million −122% of revenue
  • Net income Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 6.82 million 11% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 65.78 million −104% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2024 Operating loss: operating costs were 291% of revenue.
  • 2025 Operating loss: operating costs were 211% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2024 2024-01-01 – 2024-12-3157675000 168054000 Derived -110379000 -64382000 Derived -45997000 Unavailable
Source
2025 2025-01-01 – 2025-12-3163262000 133483000 Derived -70221000 -77036000 Derived 6815000 Unavailable
Source

Amounts are exact, in Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 63.3M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.68.3M51.2M34.2M17.1M0.020242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw)Source evidence
2024Revenue57675000
2025Revenue63262000

Revenue growth

Change in revenue from the same financial period one year earlier.

9.7% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.10.5%7.8%5.2%2.6%0.0%20242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2024Year over yearNo prior comparable period
2025Year over year9.7%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -111% 2025
Net margin 10.8% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.27%-32%-90%-149%-208%20242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2024Operating margin-191.4%
2025Operating margin-111%
2024Net margin-79.8%
2025Net margin10.8%
2024Free cash flow marginNot reported
2025Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw -65.8M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6.4M-16.8M-40.1M-63.4M-86.6M20242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw)Source evidence
2024Operating cash flow-80191000
2025Operating cash flow-65777000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw)Source evidence
2024Free cash flowUnavailable
2025Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Liabilities / assetsNot reportedNo source recorded
2025-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded
2025-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 46 million
Exact value

Exact value: -45997000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw

2024-01-01 – 2024-12-31: -45997000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 80.19 million
Exact value

Exact value: -80191000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw

2024-01-01 – 2024-12-31: -80191000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2025-01-01 – 2025-12-31
Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 6.82 million
Exact value

Exact value: 6815000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw

2025-01-01 – 2025-12-31: 6815000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw 65.78 million
Exact value

Exact value: -65777000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw

2025-01-01 – 2025-12-31: -65777000 Unit_Standard_USD_UvvvBbca-UCyOnSMT_U4uw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

83 filings · 8,172 latest values · 8,172 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001429260, 1429260, CNDO, FBIO, FBIOP, edgar:1429260

Also known as CORONADO BIOSCIENCES INC, Fortress Biotech, Inc., Fortress Biotech, Inc.